Celsion and Hisun plan broader Chinese alliance for ThermoDox in HCC
This article was originally published in Scrip
Executive Summary
As one of the most common cancers in China, it is not surprising that hepatocellular carcinoma (HCC) is attracting the attention of domestic and foreign companies alike in the country.